Studies advance methods to avert toxicity that can accompany immunotherapy – Medical Xpress
Medical Xpress |
Studies advance methods to avert toxicity that can accompany immunotherapy
Medical Xpress The first CAR T-cell product was recently approved by the U.S. Food and Drug Administration to treat certain leukemias. That product, like the one studied by the Fred Hutch team, reprograms patients’ immune cells to kill blood cancer cells bearing a … |
Medical Xpress |
New study could point to solution for deadly immunotherapy side effects
GeekWire The study, which was based on a clinical trial of 133 patients, is the largest to date on the side effects of CAR T immunotherapy. It was published early Thursday in the journal Cancer Discovery. “It’s essential that we understand the potential side … Studies advance methods to avert toxicity that can accompany immunotherapyMedical Xpress CAR-T cancer therapy is potent, but can be lethal. New research helps explain whySTAT Fred Hutch studies advance methods to avert toxicity that can accompany immunotherapyEurekAlert (press release) Washington Post all 5 news articles » |
Economic Times |
Government imposes restrictions on stem cell banking, therapy to curb “rampant” unethical practices
Economic Times NEW DELHI: The government’s latest guidelines on stem cell research has imposed restrictions on stem cell banking and therapeutic use in a move to check “rampant” unethical practices in this field and safeguard patients receiving such treatments. |
KSMU Radio |
With GMO Struggle In Mind, Food Industry Vying For Public Trust With CRISPR Discussion
KSMU Radio The technology is called Clustered Regularly Interspaced Short Palindromic Repeats, or CRISPR. It’s a technique that Alison Van Eenennaam, an animal genetics professor at University of California, Davis, says can de-activate a gene. Or, as she puts it … |